患者对中度至重度亚托皮性皮炎治疗特征的偏好:一个离散选择实验
Steven R Feldman1, Annie Guerin2, Marjolaine Gauthier-Loiselle2
1Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
The Journal of dermatological treatment
|May 5, 2024
概括
患有中度至重度亚托皮炎 (AD) 的患者优先考虑控制和尽量减少不良事件 (AE),而不是服用频率. 了解这些偏好对于更好的治疗决策和AD管理结果至关重要.
科学领域:
- 皮肤病学 皮肤病学
- 健康 结果 研究 研究 结果
- 患者报告的结果
背景情况:
- 关于美国中度至重度亚托皮性皮肤炎 (AD) 治疗偏好的数据有限.
- 评估患者的偏好对于改善AD治疗策略至关重要.
研究的目的:
- 评估美国成年人中度至重度亚托皮性皮肤炎 (AD) 的治疗偏好.
- 确定影响阿兹海默症患者治疗选择的关键属性.
主要方法:
- 在2023年6月进行了一项在线离散选择实验调查.
- 参与者包括美国成年人,自我报告中度至重度的AD或之前的全身治疗经验.
- 条件后勤回归模型用于估计偏好权重和治疗属性的相对重要性 (RI).
主要成果:
- 患者优先选择具有更高疗效,更低副作用风险和更少频繁的血液检查的治疗方法.
- 主要偏好包括控制 (38% RI),癌症风险 (23%) 和呼吸道感染 (18%).
- 总体而言,AE属性占相对重要性的一半以上,而服用频率的影响最小.
结论:
- 中度至重度AD患者的偏好强烈偏好和安全,而不是给药细节.
- 将患者的偏好纳入共享决策可以提高对AD的满意度,参与度和临床结果.
- 这些发现强调了以患者为中心的护理在治疗亚托皮性皮肤炎方面的重要性.
更多相关视频
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Hypersensitivities
615
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
615
Changes in Skin Color: Clinical Perspectives
2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K
Skin Diseases and Disorders
3.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
3.8K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Antiasthma Drugs: Leukotriene Modifiers
281
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
281


